Skip to main content
. 2022 Feb 2;9(2):210705. doi: 10.1098/rsos.210705

Figure 7.

Figure 7.

(a) Profiles of concomitant TGF-β inhibitor and IFN-β infusion protocol and corresponding concentration dynamics of C, I, L, G, S, and (b) average levels of N2/N1 (τ) for each period (Pt,Pcf,Pr) starting at different initial conditions Q1, Q2, Q3, Q4.